Does EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC Cause Therapy cessation? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapy cessation have been filed in association with EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC. This represents 1.3% of all adverse event reports for EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC.
5
Reports of Therapy cessation with EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC
1.3%
of all EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy cessation From EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC?
Of the 5 reports, 3 (60.0%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC Cause?
Myasthenia gravis (58)
Fatigue (38)
Injection site pain (29)
Asthenia (27)
Fall (26)
Drug ineffective (24)
Muscular weakness (24)
Myasthenia gravis crisis (24)
Injection site erythema (23)
Chronic inflammatory demyelinating polyradiculoneuropathy (19)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC Alternatives Have Lower Therapy cessation Risk?
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC vs EFINACONAZOLE
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC vs EFLORNITHINE
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC vs EFMOROCTOCOG ALFA
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC vs EFTRENONACOG ALFA
EFGARTIGIMOD ALFA\HYALURONIDASE-QVFC vs EGG PHOSPHOLIPIDS\GLYCERIN\MEDIUM-CHAIN TRIGLYCERIDES\SOYBEAN OIL